# Viyash Scientific Ltd (VIYASH)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹247.54
Day Change: -1.65%
52W High: ₹240
52W Low: ₹178.13
Market Cap: ₹9,841 Cr

## Valuation
P/E: 87.4
P/B: 6.96
EPS: ₹2.58
Book Value: ₹32.38
Dividend Yield: 0%

## Returns
1Y Return: 22.88%

## Profitability
ROE: 0%
ROCE: 20.04%
Debt/Equity: 0.55
Revenue Growth: 119.6%
Profit Growth: 569.2%
EBITDA Margin: 19.59%
Operating Margin: 13.7%

## About
Viyash Scientific Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Viyash Scientific Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- BSE Filing: Announcement under Regulation 30 (LODR)-Change in Management

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:06.460Z
Price History Updated: 2026-05-18T22:58:28.223Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:28.223Z
Quant Updated: 2026-05-18T22:58:28.223Z
Sentiment Updated: 2026-05-18T22:58:28.223Z
Financials Status: current
Financials Updated: 2026-05-18T11:30:32.463Z
Financials Last Attempt: 2026-05-18T11:30:32.463Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹395 Cr
Operating Profit: ₹6 Cr (OPM 2%)
Net Profit: ₹-110 Cr
Tax: ₹-110 Cr

## Annual P&L History
Mar 2015: Rev ₹395Cr | PAT ₹-110Cr | OPM 2%
Mar 2016: Rev ₹443Cr | PAT ₹-12Cr | OPM 4%
Mar 2017: Rev ₹606Cr | PAT ₹-16Cr | OPM 9%

## Balance Sheet (Mar 2015)
Total Assets: ₹623 Cr
Total Liabilities: ₹623 Cr
Borrowings: ₹418 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rajaram  Narayanan, MD, CEO & Director
- Phillip  Trott, Assoc. VP, Head of Legal & Chief Risk Officer
- Yoshita  Vora, Company Secretary & Compliance Officer
- Ramakant  Singani, Chief Financial Officer
- Ramesh Kumar Pillai, Corporate Vice President of Ra Qa and Technical Services

---
Source: rupiya.io/stocks/viyash
Disclaimer: For research and education only. Not investment advice.